![George Kokke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
George Kokke
Director of Finance/CFO at NOUS Imaging , Inc.
Profile
George Kokke is currently the Chief Financial Officer & Director at Turing Medical technologies, Inc. He was previously a Director at ProteoMediX AG.
George Kokke active positions
Companies | Position | Start |
---|---|---|
NOUS Imaging , Inc.
![]() NOUS Imaging , Inc. Packaged SoftwareTechnology Services Nous Imaging, Inc. is a medical imaging software company that specializes in developing unique solutions in the MR space. The private company is based in St. Louis, MO. The company's mission is to deliver cost-effective imaging enhancements, establish next-generation data analytics, and create a new patient-centric experience in the MR suite. The company was founded by Nico Dosenbach, Damien Fair, and Hans Schoepflin, and the CEO is Ken Bruener. | Director of Finance/CFO | - |
Former positions of George Kokke
Companies | Position | End |
---|---|---|
ProteoMediX AG
![]() ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
NOUS Imaging , Inc.
![]() NOUS Imaging , Inc. Packaged SoftwareTechnology Services Nous Imaging, Inc. is a medical imaging software company that specializes in developing unique solutions in the MR space. The private company is based in St. Louis, MO. The company's mission is to deliver cost-effective imaging enhancements, establish next-generation data analytics, and create a new patient-centric experience in the MR suite. The company was founded by Nico Dosenbach, Damien Fair, and Hans Schoepflin, and the CEO is Ken Bruener. | Technology Services |
ProteoMediX AG
![]() ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
- Stock Market
- Insiders
- George Kokke